Archived News Headlines

We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content. Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.

Employers Say Specialty Drugs a Factor Behind Rising Costs

(The Center for Biosimilars) Apr 17, 2019 - Last year, the average rise of per employee cost of specialty drugs was 12%, with oncology making up the largest category.

IBM Halting Sales Of Watson AI Tool For Drug Discovery Amid Sluggish Growth

(STAT Plus) Apr 18, 2019 - Citing lackluster financial performance, IBM is halting development and sales of a product that uses its Watson artificial intelligence software to help pharmaceutical companies discover new drugs, according to a person familiar with the company’s internal decision-making.

Preventing Triple Negative Breast Cancer From Spreading

(University of Missouri) Apr 17, 2019 - Protein could be key to providing a precision medicine treatment to prevent the spread of cancer in people diagnosed with triple-negative breast cancer, MU study finds.

First Opinion: Medicare Part D Must Evolve To Help People Fight Cancer

(STAT) Apr 18, 2019 - New advances won’t realize their full potential unless patients have access to them.

New Study Targets Achilles’ Heel Of Pancreatic Cancer, With Promising Results

(Salk Institute) Apr 17, 2019 - Salk Institute researchers, along with an international team of collaborators, have uncovered the role of a signaling protein that may be the Achilles’ heel of pancreatic cancer.

A Biotech Startup’s Lofty Goal: Kill Cancer With Pills That Target RNA Instead Of Proteins

(STAT) Apr 18, 2019 - On Thursday, the company is announcing an early breakthrough. Arrakis’ screening work has identified “hits” — oral drug-like compounds — that block the RNA machinery needed to make some well-known, cancer-causing proteins long thought to be beyond the reach of drug makers.

Detecting DNA Defects

(Harvard Gazette) Apr 15, 2019 - Scientists from Harvard Medical School (HMS) have designed an algorithm that can successfully “read” the molecular signature of the cancer-driving defect and identify patients who could benefit from treatment with PARP inhibitors.

Vaxiion Therapeutics Initiates Phase 1 Clinical Trial of VAX014 for the Treatment of Non-Muscle Invasive Bladder Cancer in the United States

(Associated Press) Apr 18, 2019 - Vaxiion Therapeutics today announced that the U.S. Food and Drug Administration (FDA) has concluded its 30-day review of the Investigational New Drug application (IND) for VAX014, and the company will now initiate a Phase 1 clinical trial for the treatment of non-muscle invasive bladder cancer (NMIBC).

Breast Cancer Blood Test Could Help To Spot Relapse Earlier

(Imperial College London [UK]) Apr 17, 2019 - A simple blood test could help to detect breast cancer relapse up to two years earlier than imaging in patients with early-stage breast cancer.

Watch This Company: Turning Point Therapeutics Shares Pop 57% After IPO

(STAT Plus) Apr 17, 2019 - Shares of Turning Point Therapeutics, a San Diego-based developer of targeted cancer drugs, soared 57% following the company’s initial public offering on Wednesday.